Literature DB >> 6454727

The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR.

C Huber, U Fink, W Leibold, F Schmalzl, P A Peterson, L Klareskog, H Braunsteiner.   

Abstract

The aim of this study was to define the significance of HLA-DR+ cells for the in vitro induction of human autoreactive T cell proliferation. Proliferation was induced by autologous or allogeneic non-T cells or EB virus-transformed LCL. Pretreatment of stimulator cells with low concentrations of RAHLA-DR and C and with high amounts of RAHLA-DR alone abolished the capacity to stimulate autologous or allogeneic T cells. This suggested that antigens associated with HLA-DR+ stimulator cells or HLA-DR itself are involved in the induction of this proliferation. At the responder cell level the cytotoxic elimination of HLA-DR+ cells as well as depletion of adherent cells by passage through Sephadex G-10 columns reduced both autoreactive and alloreactive responsiveness. Responses of serologically and physically depleted populations were both restored by reconstitution with mitomycin-C treated autologous adherent cells. These cells were resistant to lysis with T cell specific antibodies and preferentially cooperated with T cells of autologous deprivation. Co-cultivation experiments further revealed that such accessory cells were capable of amplifying T cell proliferation in the presence of suboptimal numbers of autologous LCL. We concluded, therefore, that an HLA-DR+-adherent cell, presumably of monocytic origin, is required for optimal proliferative responsiveness of both autoreactive and alloreactive T cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454727

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation.

Authors:  D Nachbaur; M Herold; B Eibl; H Glassl; H Schwaighofer; C Huber; A Gächter; M Pichl; D Niederwieser
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.

Authors:  M Vanoli; R Scorza Smeraldi; G Fabio; P Bonara; M G Sabbadini; C Zanussi
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

3.  DR antigen expression on ovarian carcinoma cells does not correlate with their capacity to elicit an autologous proliferative response.

Authors:  M Di Bello; V Lucchini; S Chiari; R Colleoni; N Colombo; A Mantovani; P Allavena
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Surface glycoproteins (S-GP) on normal and malignant human leukocytes.

Authors:  E Leiter; R Pfister; D Lutz; G Michlmayr; H Gadner; C Gattringer; F Schmalzl; H Braunsteiner; C Huber
Journal:  Blut       Date:  1985-03

5.  Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens.

Authors:  M Kasahara; H Ikeda; K Ogasawara; N Ishikawa; T Okuyama; Y Fukasawa; H Kojima; H Kunikane; S Hawkin; T Ohhashi
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

6.  Large granular lymphocytes: morphological and functional properties. I. Results in normals.

Authors:  G Gastl; F Schmalzl; D Huhn; C Gattringer; C Huber
Journal:  Blut       Date:  1983-06

7.  [Density distribution of human lymphocytes. I. Results of research on normal lymphoid tissue].

Authors:  C Huber; D Niederwieser; G Gastl; K Zier; H Braunsteiner
Journal:  Blut       Date:  1982-12

8.  Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies.

Authors:  B Kircher; K Lätzer; G Gastl; D Nachbaur
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  [Neopterin, a new biochemical marker for clinical assessment of cell-mediated immune response].

Authors:  C Huber; D Fuchs; D Niederwieser; A Hausen; G Reibnegger; K Nilsson; H Wachter
Journal:  Klin Wochenschr       Date:  1984-02-01

10.  DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cells.

Authors:  F Vánky; E Klein; J Willems
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.